BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8305 related articles for article (PubMed ID: 15167584)

  • 21. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
    Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
    Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
    Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
    Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS
    Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection.
    Fantus D; Dai H; Ono Y; Watson A; Yokota S; Mohib K; Yoshida O; Ross MA; Watkins SC; Ramaswami B; Valusjkikh A; Rothstein DM; Thomson AW
    Transplantation; 2017 Dec; 101(12):2830-2840. PubMed ID: 28885497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin delays allograft rejection in obese graft recipients through induction of myeloid-derived suppressor cells.
    Deißler A; Della Penna A; van Geffen C; Gonzalez-Menendez I; Quintanilla-Martinez L; Günther A; Schneiderhan-Marra N; Hartl D; Nürnberg B; Königsrainer A; Kolahian S; Quante M
    Immunol Lett; 2021 Aug; 236():1-11. PubMed ID: 34015361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice.
    Brändle D; Joergensen J; Zenke G; Bürki K; Hof RP
    Transplantation; 1998 Jun; 65(11):1489-93. PubMed ID: 9645808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
    Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
    Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
    Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
    Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
    J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 416.